7,787 Shares in Integer Holdings Co. (NYSE:ITGR) Purchased by Intech Investment Management LLC

Intech Investment Management LLC acquired a new position in Integer Holdings Co. (NYSE:ITGR - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,787 shares of the medical equipment provider's stock, valued at approximately $1,012,000.

Several other institutional investors also recently bought and sold shares of the stock. Blue Trust Inc. increased its position in Integer by 460.4% during the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider's stock valued at $658,000 after buying an additional 4,636 shares in the last quarter. Earnest Partners LLC lifted its position in Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock valued at $139,911,000 after purchasing an additional 37,340 shares in the last quarter. Great Lakes Advisors LLC raised its holdings in Integer by 56.7% during the second quarter. Great Lakes Advisors LLC now owns 45,218 shares of the medical equipment provider's stock valued at $5,236,000 after acquiring an additional 16,355 shares during the period. SG Americas Securities LLC bought a new stake in Integer during the third quarter valued at about $651,000. Finally, Wealth Enhancement Advisory Services LLC bought a new stake in Integer during the second quarter valued at about $247,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Price Performance

ITGR stock traded up $2.02 during mid-day trading on Thursday, reaching $140.80. The company's stock had a trading volume of 171,859 shares, compared to its average volume of 308,520. The stock has a market cap of $4.72 billion, a PE ratio of 43.46, a P/E/G ratio of 2.01 and a beta of 1.09. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a fifty-two week low of $84.75 and a fifty-two week high of $141.27. The company's 50 day moving average is $131.15 and its two-hundred day moving average is $124.17.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The firm's quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company posted $1.27 EPS. Equities research analysts expect that Integer Holdings Co. will post 5.34 EPS for the current year.

Wall Street Analysts Forecast Growth

ITGR has been the topic of several research reports. KeyCorp lifted their target price on Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a report on Tuesday, October 15th. Citigroup lifted their price target on Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 1st. Piper Sandler restated an "overweight" rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Bank of America boosted their target price on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Tuesday, October 1st. Finally, Truist Financial lowered their price target on Integer from $150.00 to $147.00 and set a "buy" rating for the company in a report on Friday, October 25th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $139.75.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.